logo

For the Inventor, By the Inventor

Madrid, Spain

Medlumics S.l.

USPTO Granted Patents = 27

% Expired Patents = 3.7



Trademarks = 1

Forward Citations = 207

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal José Luis Rubio Guivernau (20 out of 20 patents)

silverMedal Eduardo Margallo Balbás (17 out of 20 patents)

bronzeMedal Juan Sancho Durá (9 out of 11 patents)

4.  Matthieu Duperron (7 out of 9 patents)

5.  Juan Lloret Soler (6 out of 6 patents)

6.  Kirill Zinoviev (5 out of 7 patents)

7.  Santiago Jiménez Valero (4 out of 4 patents)

8.  Alejandro Barriga Rivera (4 out of 4 patents)

9.  Jorge Jimenez (3 out of 32 patents)

10.  Sara Mas Gómez (3 out of 5 patents)

11.  Carlos Sanz Moreno (3 out of 5 patents)

12.  Alexandre Romoscanu (3 out of 23 patents)

13.  James L Greene (3 out of 3 patents)

14.  David Herranz (2 out of 3 patents)

15.  Juan Sancho (2 out of 2 patents)


Core Competencies:
Ablation Catheter
Optical Analysis
Lesion Prediction
Optical Coherence Tomography
Waveguide Fabrication
Bi-refringence Compensation
Pulsed Fields
Interferometry
Optical Beam Scanner
Chromatic Dispersion
Miniaturized Packaging

27 patents:

1. 12569286 - Accuracy of ablation model through synchronization (2026-03-10),
2. 12558188 - Systems and methods for optical analysis and contact stability using ablation catheters (2026-02-24),
3. 12285237 - Systems and methods for optical analysis and lesion prediction using ablation catheters (2025-04-29),
4. 12239363 - Ablation catheter with a patterned textured active area (2025-03-04),
5. 12232807 - Methods, devices, and support structures for assembling optical fibers in catheter tips (2025-02-25),
6. 12011218 - Methods, devices, and support structures for assembling optical fibers in catheter tips (2024-06-18),
7. 11517199 - Crossing coronary occlusions (2022-12-06),
8. 11464412 - Bi-refringence compensated waveguides (2022-10-11),
9. 11402579 - Techniques for fabricating waveguide facets and die separation (2022-08-02),
10. 11357569 - Optical-guided ablation system for use with pulsed fields or other energy sources (2022-06-14),
11. 10835313 - Radiofrequency ablation catheter with optical tissue evaluation (2020-11-17),
12. 10820806 - Bi-refringence compensated waveguides (2020-11-03),
13. 10206584 - Optical coherence tomography probe for crossing coronary occlusions (2019-02-19),
14. 10194981 - Radiofrequency ablation catheter with optical tissue evaluation (2019-02-05),
15. 10113858 - Distributed delay-line for low-coherence interferometry (2018-10-30),
Company Overview
Medlumics S.L. is a Madrid-based company specializing in advanced medical technologies, particularly in the field of optical coherence tomography (OCT). The organization focuses on developing innovative imaging solutions that enhance diagnostic capabilities in various medical applications. By leveraging cutting-edge research and technology, Medlumics aims to improve patient outcomes through precise and minimally invasive procedures, contributing to the evolution of healthcare practices in Spain and beyond.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

27 Patents

#16 in Madrid

#67 in Spain

#24,034 in the World

Madrid, ES
Madrid, Spain

Medlumics S.l.

Forward Citations = 207

30 inventors:

goldMedal José Luis Rubio Guivernau (20 out of 20 patents)

silverMedal Eduardo Margallo Balbás (17 out of 20 patents)

bronzeMedal Juan Sancho Durá (9 out of 11 patents)

4.  Matthieu Duperron (7 out of 9 patents)

5.  Juan Lloret Soler (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medlumics S.l.. Retrieved from https://idiyas.com/company/medlumics-s-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…